DexCom
DXCM
975 hedge funds and large institutions have $47.1B invested in DexCom in 2023 Q4 according to their latest regulatory filings, with 196 funds opening new positions, 327 increasing their positions, 356 reducing their positions, and 113 closing their positions.
73% more first-time investments, than exits
New positions opened: 196 | Existing positions closed: 113
47% more funds holding in top 10
Funds holding in top 10: 17 → 25 (+8)
37% more capital invested
Capital invested by funds: $34.4B → $47.1B (+$12.7B)
8% more funds holding
Funds holding: 902 → 975 (+73)
3.46% more ownership
Funds ownership: 94.92% → 98.38% (+3.5%)
8% less repeat investments, than reductions
Existing positions increased: 327 | Existing positions reduced: 356
22% less call options, than puts
Call options by funds: $824M | Put options by funds: $1.05B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$537M |
| 2 |
Artisan Partners
Milwaukee,
Wisconsin
|
+$375M |
| 3 |
AI
Alphabet Inc
Mountain View,
California
|
+$309M |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
+$275M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$220M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$400M |
| 2 |
ClearBridge Investments
New York
|
-$329M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$302M |
| 4 |
Millennium Management
New York
|
-$179M |
| 5 |
Brown Advisory
Baltimore,
Maryland
|
-$132M |
DXCM Hedge Fund Activity: Q4 2023 in Review
975 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q4 2023, worth a combined $47.1B — up 37% from $34.4B a quarter earlier.
Buyers outnumbered sellers: 196 funds opened new DXCM positions and 113 closed out — a net gain of 83 holders — while 327 added to existing stakes and 356 trimmed.
The largest buyer was Capital World Investors, adding an estimated $537M. The largest seller was Jennison Associates, cutting an estimated $400M.
- 975 institutional investors held DexCom (DXCM) as of Q4 2023, up from 902 in Q3 2023.
- Funds reported $47.1B of DexCom stock for Q4 2023, up 37% quarter-over-quarter.
- 196 funds opened new DexCom positions in Q4 2023 and 113 closed out, a net change of +83 holders.
- The largest DexCom buyer in Q4 2023 was Capital World Investors, an estimated $537M added.
- The largest DexCom seller in Q4 2023 was Jennison Associates, an estimated $400M sold.
Based on aggregated 13F filings for Q4 2023.